• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康与疾病状态下对卡氏肺孢子虫抗原的血清学反应。

Serologic responses to Pneumocystis carinii antigens in health and disease.

作者信息

Peglow S L, Smulian A G, Linke M J, Pogue C L, Nurre S, Crisler J, Phair J, Gold J W, Armstrong D, Walzer P D

机构信息

Department of Internal Medicine, University of Cincinnati College of Medicine, Ohio.

出版信息

J Infect Dis. 1990 Feb;161(2):296-306. doi: 10.1093/infdis/161.2.296.

DOI:10.1093/infdis/161.2.296
PMID:2299209
Abstract

Serum antibodies to human Pneumocystis carinii antigens were measured in greater than 400 specimens from different population groups by the immunoblotting technique. Serologic responses varied during the first 2 years of life, but in children greater than or equal to 2 1/2 years and in adults antibodies to a 40-kDa band were found in greater than 85% of the specimens; antigens to bands of 66, 92, and 116 kDa were also detected frequently. The prevalence of serum antibodies in immunosuppressed patients varied at different institutions and was usually lower than that of healthy controls. Seven (41%) of 17 patients with single episodes of pneumocystosis and 13 (93%) of 14 patients with recurrent episodes followed sequentially developed active serum IgM and/or IgG antibody responses to the 40-kDa antigen. Serologic responses to P. carinii were also detected, though less frequently, by immunofluorescence. These data suggest that the 40-kDa antigen is a major marker of P. carinii infection and that immunoblotting is useful in measuring serum antibody responses to the organism in both normal and immunocompromised hosts.

摘要

采用免疫印迹技术检测了来自不同人群组的400多份标本中针对人卡氏肺孢子虫抗原的血清抗体。在生命的最初2年中血清学反应有所不同,但在2岁半及以上的儿童和成人中,超过85%的标本中发现了针对一条40 kDa条带的抗体;66 kDa、92 kDa和116 kDa条带的抗原也经常被检测到。免疫抑制患者血清抗体的流行率在不同机构有所不同,且通常低于健康对照。17名单发肺孢子虫病患者中有7名(41%),14名复发患者中有13名(93%)随后依次出现了针对40 kDa抗原的活性血清IgM和/或IgG抗体反应。通过免疫荧光也检测到了对卡氏肺孢子虫的血清学反应,不过频率较低。这些数据表明,40 kDa抗原是卡氏肺孢子虫感染的主要标志物,免疫印迹法在检测正常宿主和免疫受损宿主中针对该病原体的血清抗体反应方面很有用。

相似文献

1
Serologic responses to Pneumocystis carinii antigens in health and disease.健康与疾病状态下对卡氏肺孢子虫抗原的血清学反应。
J Infect Dis. 1990 Feb;161(2):296-306. doi: 10.1093/infdis/161.2.296.
2
Antibody response to a major human Pneumocystis carinii surface antigen in patients without evidence of immunosuppression and in patients with suspected atypical pneumonia.对无免疫抑制证据患者及疑似非典型肺炎患者体内针对一种主要人卡氏肺孢子虫表面抗原的抗体反应。
Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):105-9. doi: 10.1007/BF01967583.
3
Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery.卡氏肺孢子虫:实验性大鼠感染及恢复过程中血清抗体的免疫印迹和免疫荧光分析
Exp Parasitol. 1987 Jun;63(3):319-28. doi: 10.1016/0014-4894(87)90179-2.
4
Application of immunoblotting to detect soluble Pneumocystis carinii antigen(s) in bronchoalveolar lavage of patients with Pneumocystis pneumonia and AIDS.免疫印迹法在检测卡氏肺孢子虫肺炎合并艾滋病患者支气管肺泡灌洗中可溶性卡氏肺孢子虫抗原的应用。
J Clin Pathol. 1990 Jul;43(7):584-6. doi: 10.1136/jcp.43.7.584.
5
Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia.人类免疫缺陷病毒感染患者中,有或无卡氏肺孢子虫肺炎的患者对卡氏肺孢子虫主要抗原的抗体反应。
J Infect Dis. 1992 Jun;165(6):1151-5. doi: 10.1093/infdis/165.6.1151.
6
Immunoblot analysis for serum antibodies to Pneumocystis carinii by age and intensity of infection in rats.
Korean J Parasitol. 1995 Sep;33(3):187-94. doi: 10.3347/kjp.1995.33.3.187.
7
Evidence for the existence of ganglioside molecules on Pneumocystis carinii from human lungs.
Parasitology. 1992 Aug;105 ( Pt 1):1-6. doi: 10.1017/s0031182000073613.
8
Infection with Pneumocystis carinii is prevalent in healthy Gambian children.卡氏肺孢子虫感染在健康的冈比亚儿童中很普遍。
Trans R Soc Trop Med Hyg. 1990 Nov-Dec;84(6):800-2. doi: 10.1016/0035-9203(90)90087-u.
9
Disseminated Pneumocystis carinii infection causing extrapulmonary organ failure: clinical, pathologic, and immunohistochemical analysis.播散性卡氏肺孢子菌感染导致肺外器官衰竭:临床、病理及免疫组化分析
Mod Pathol. 1990 Jan;3(1):25-30.
10
The level of IgG and IgM in Pneumocystis carinii infection.卡氏肺孢子虫感染中IgG和IgM的水平。
J Egypt Soc Parasitol. 1989 Dec;19(2):635-9.

引用本文的文献

1
Immune responses of different hosts to infection.不同宿主对感染的免疫反应。
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0247-2024. Print 2025 Jul.
2
Trends in the Epidemiology of Pneumonia in Immunocompromised Patients without HIV Infection.无HIV感染的免疫功能低下患者肺炎的流行病学趋势
J Fungi (Basel). 2023 Jul 31;9(8):812. doi: 10.3390/jof9080812.
3
A therapeutic vaccine strategy to prevent pneumonia in an immunocompromised host in a non-human primate model of HIV and co-infection.一种治疗性疫苗策略,用于预防 HIV 和合并感染的非人类灵长类动物模型中免疫功能低下宿主的肺炎。
Front Immunol. 2022 Dec 6;13:1036658. doi: 10.3389/fimmu.2022.1036658. eCollection 2022.
4
Sero-Epidemiology of Infection among Infants, Children, and Adults in Chile.智利婴幼儿及成人感染的血清流行病学研究
J Fungi (Basel). 2022 Jan 29;8(2):136. doi: 10.3390/jof8020136.
5
Pneumonia: Immunity, Vaccines, and Treatments.肺炎:免疫、疫苗与治疗
Pathogens. 2021 Feb 19;10(2):236. doi: 10.3390/pathogens10020236.
6
Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.诊断耶氏肺孢子菌肺炎:当前方法与新途径综述
Med Mycol. 2020 Nov 10;58(8):1015-1028. doi: 10.1093/mmy/myaa024.
7
A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.肺炎支原体生物学与流行病学的分子窗口
Clin Microbiol Rev. 2018 Jun 13;31(3). doi: 10.1128/CMR.00009-18. Print 2018 Jul.
8
The lung microbiome in patients with pneumocystosis.肺微生物组在肺囊虫病患者中的研究。
BMC Pulm Med. 2017 Dec 4;17(1):170. doi: 10.1186/s12890-017-0512-5.
9
Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study.欧洲耶氏肺孢子菌的多样性:一项多中心观察性研究。
EBioMedicine. 2017 Aug;22:155-163. doi: 10.1016/j.ebiom.2017.06.027. Epub 2017 Jun 29.
10
Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?通过对医学重要真菌进行基因分型来研究临床问题:为何以及如何进行?
Clin Microbiol Rev. 2017 Jul;30(3):671-707. doi: 10.1128/CMR.00043-16.